Menu
Recruiting NCT07224906

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

— Observational Pulmonary Hypertension Congestive Heart Failure(CHF) Valve Disease, Heart

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Pulmonary Hypertension, Congestive Heart Failure(CHF), Valve Disease, Heart. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart

Overview

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Primary outcome measures

  • Association between device measurements and Pulmonary Capillary Wedge Pressure [Time frame: Day 1]

Eligibility criteria

Inclusion criteria

  • Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
  • Subjects can be any gender but must be age 18 or older.
  • Subject is able and willing to provide informed consent and HIPAA authorization.
  • Subject is able and willing to meet all study requirements.
  • Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

Exclusion criteria

  • Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Boulder Heart — Boulder

Identifiers

NCT: NCT07224906 · PRT-020

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗